← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
CGTBiologicstaleHebei Senlang Biotechnology Inc…Phase 2

BCMA CAR-T (BCMA CAR-T)

Multiple Myeloma, Newly Diagnosed · BCMA

#BCMA#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 4상태 ACTIVE
ADCBiologicstaleBioNTech SEPhase 3

BNT324 (BNT324)

Advanced Lung Cancer · Metastatic Castration-resistant Prostate

#MetastaticCastration-resistantPr#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 4상태 RECRUITING
ADCBiologicstaleHoffmann-La RochePhase 2

Belvarafenib (Belvarafenib)

Solid Tumors · Solid Tumors

#SolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
CGTBiologicstaleKite Pharma (a Gilead Company)Phase 1

CART-EGFR-IL13Ra2 Cells (CART-EGFR-IL13Ra2 Cells)

Glioblastoma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 4상태 RECRUITING
CGTBiologicstaleChongqing Precision Biotech Co.…Phase 2

CD123 targeted CAR-NK cells (CD123 targeted CAR-NK cells)

Acute Myeloid Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 4상태 RECRUITING
CGTBiologicstaleShenzhen Genocury Biotech Co., …Preclinical

CD19/BCMA-targeted CAR-T lentiviral vector drug (CD19/BCMA-targeted CAR-T lentiviral vector drug)

Autoimmune Diseases · CD19

#CD19#CGT#Preclinical#세포유전치료#CAR-T+3
임상시험 4상태 RECRUITING
CGTBiologicstaleCity of Hope Medical CenterPhase 1

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T-lymphocytes)

B Acute Lymphoblastic Leukemia; Recurrent Acute Lymphoblastic Leukemia · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 4상태 RECRUITING
CGTBiologicstaleHuda SalmanPhase 1

CD4CAR (CD4CAR)

Chronic Myelomonocytic Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 4상태 RECRUITING
CGTBiologicstaleiCell Gene TherapeuticsPhase 1

CD7CAR T cells (CD7CAR T cells)

Relapsed/Refractory, High Risk Hematologic Malignancies; T-ALL/Lymphoma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 4상태 ACTIVE
CGTBiologicstaleChina Immunotech (Beijing) Biot…Phase 1

CMV-TCR-T cells (CMV-TCR-T cells)

CMV Infection After Allogenic HSCT · Allogeneic Hematopoietic Stem Cell Trans

#AllogeneicHematopoieticStemCellT#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 4상태 ACTIVE
ADCBiologicstaleDay One Biopharmaceuticals, Inc.Phase 1

DAY301 (DAY301)

Advanced or Metastatic Solid Tumors · Advanced or Metastatic Solid Tumors

#AdvancedorMetastaticSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
ADCBiologicstaleDualityBio Inc.Phase 2

DB-1311/BNT324 (DB-1311/BNT324)

Solid Tumors · Solid Tumors

#SolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 2

DLL3-CAR-NK cells (DLL3-CAR-NK cells)

Extensive Stage Lung Small Cell Cancer · SCLC, Extensive Stage

#SCLCExtensiveStage#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 4상태 RECRUITING
CGTBiologicFrontera TherapeuticsPhase 2

FT-003 (FT-003)

Diabetic Macular Edema · Neovascular Age-related Macular Degenera

#NeovascularAge-relatedMacularDeg#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 4상태 RECRUITING
AntibodystaleEisai Inc.Phase 2

Farletuzumab ecteribulin (Farletuzumab ecteribulin)

Solid Tumor · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+2
효능 ORR 20%임상시험 4상태 RECRUITING
CGTBiologicPolina StepenskyPhase 2

HBI0101 CART (HBI0101 CART)

Multiple Myeloma, Refractory to Standard Treatment; Multiple Myeloma, Relapsed · Systemic Sclerosis (SSc)

#SystemicSclerosisSSc#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 4상태 RECRUITING
ADCBiologicstaleFBD Biologics LimitedPhase 2

HCB101 (HCB101)

Solid Cancer · Solid Cancer

#SolidCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
ADCBiologicstaleAbbViePhase 2

IMGN632 (IMGN632)

Blastic Plasmacytoid Dendritic Cell Neoplasm; Myeloproliferative Neoplasm · Blastic Plasmacytoid Dendritic Cell Neop

#BlasticPlasmacytoidDendriticCell#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 4상태 RECRUITING
AntibodystaleEli Lilly and CompanyPhase 2

Icrucumab (Icrucumab)

Colon Cancer; Rectal Cancer · Carcinoma of Urinary Tract

#CarcinomaofUrinaryTract#Antibody#Phase2#항체#면역항체+4
효능 ORR 28.8%임상시험 4상태 ACTIVE
CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

KRAS TCR-Transduced PBL (KRAS TCR-Transduced PBL)

Metastatic Solid Cancers; Colorectal Cancer · Gastrointestinal Carcinoma

#GastrointestinalCarcinoma#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 4상태 RECRUITING

56 / 209 페이지

← 이전다음 →